D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 63 Citations 12,182 168 World Ranking 6693 National Ranking 3114

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • DNA
  • Cancer

Hava Avraham focuses on Cell biology, Molecular biology, Cancer research, Proto-oncogene tyrosine-protein kinase Src and Tyrosine phosphorylation. She studied Cell biology and Integrin that intersect with Extracellular matrix. Her Molecular biology research incorporates themes from Immunoprecipitation, Kinase activity, Cell cycle, Regulation of gene expression and Retinoic acid.

Her Cancer research research includes elements of Carcinogenesis, Breast cancer and Vascular permeability. The study incorporates disciplines such as Tyrosine kinase and Receptor tyrosine kinase in addition to Tyrosine phosphorylation. Her research investigates the connection between Phosphorylation and topics such as Signal transduction that intersect with problems in Kinase.

Her most cited work include:

  • Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 (428 citations)
  • RAFTK/Pyk2-mediated cellular signalling. (405 citations)
  • Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (335 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Cell biology, Molecular biology, Cancer research, Signal transduction and Proto-oncogene tyrosine-protein kinase Src. Her is involved in several facets of Cell biology study, as is seen by her studies on Tyrosine phosphorylation, Phosphorylation, Focal adhesion, Focal Adhesion Kinase 2 and Megakaryocyte. Her Molecular biology research includes themes of Haematopoiesis, Complementary DNA, Receptor, Megakaryocytopoiesis and Antibody.

Hava Avraham has included themes like Carcinogenesis, Breast cancer, Kinase and Internal medicine in her Cancer research study. Her Proto-oncogene tyrosine-protein kinase Src study combines topics from a wide range of disciplines, such as Tyrosine kinase and Kinase activity. Her work carried out in the field of Tyrosine kinase brings together such families of science as Cell signaling and Receptor tyrosine kinase.

She most often published in these fields:

  • Cell biology (40.35%)
  • Molecular biology (40.94%)
  • Cancer research (26.32%)

What were the highlights of her more recent work (between 2007-2020)?

  • Cell biology (40.35%)
  • Endocannabinoid system (5.85%)
  • Cancer research (26.32%)

In recent papers she was focusing on the following fields of study:

Cell biology, Endocannabinoid system, Cancer research, Breast cancer and Molecular biology are her primary areas of study. Her Cell biology study frequently draws parallels with other fields, such as Cannabinoid receptor. Her Endocannabinoid system research is multidisciplinary, incorporating elements of Cannabinoid and Pharmacology.

Hava Avraham interconnects Beta-catenin, Wnt signaling pathway, Signal transduction and Regulation of gene expression in the investigation of issues within Cancer research. Her research integrates issues of Tight junction and Metastasis in her study of Breast cancer. Hava Avraham performs integrative Molecular biology and Doublecortin research in her work.

Between 2007 and 2020, her most popular works were:

  • Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain (87 citations)
  • Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (65 citations)
  • Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain. (65 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

Her scientific interests lie mostly in Blood–brain barrier, Tight junction, Breast cancer, Pathology and Brain metastasis. Her Tight junction research includes elements of Cannabinoid Receptor Modulators, Cannabinoid, Endocannabinoid system, Endothelium and Pharmacology. Her research investigates the connection with Breast cancer and areas like Cancer cell which intersect with concerns in Cancer stem cell.

Her studies in Pathology integrate themes in fields like Endothelial stem cell, Tumor necrosis factor alpha, Cancer research, Mammary tumor and Inflammation. Her Brain metastasis research is multidisciplinary, incorporating elements of Angiopoietin 2, Brain tumor, Triple-negative breast cancer and In vivo. Cancer is the subject of her research, which falls under Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

James Lee;Alane Gray;Jean Yuan;Shiuh-Ming Luoh.
Proceedings of the National Academy of Sciences of the United States of America (1996)

568 Citations

RAFTK/Pyk2-mediated cellular signalling.

Hava Avraham;Shin-Young Park;Karin Schinkmann;Shalom Avraham.
Cellular Signalling (2000)

546 Citations

Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain

Shalom Avraham;Roanna London;Yigong Fu;Setsuo Ota.
Journal of Biological Chemistry (1995)

443 Citations

Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.

Byeong-Chel Lee;Tae-Hee Lee;Shalom Avraham;Hava Karsenty Avraham.
Molecular Cancer Research (2004)

375 Citations

Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1

Tae-Hee Lee;Seyha Seng;Masayuki Sekine;Cimona Hinton.
PLOS Medicine (2007)

313 Citations

Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial Cells

Zivotije Radisavljevic;Hava Avraham;Shalom Avraham.
Journal of Biological Chemistry (2000)

295 Citations

Role of Vascular Endothelial Growth Factor in the Stimulation of Cellular Invasion and Signaling of Breast Cancer Cells

Daniel J. Price;Tihomir Miralem;Shuxian Jiang;Robert Steinberg.
Cell Growth & Differentiation (2001)

289 Citations

Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability.

Tae-Hee Lee;Hava Karsenty Avraham;Shuxian Jiang;Shalom Avraham.
Journal of Biological Chemistry (2003)

283 Citations

The Related Adhesion Focal Tyrosine Kinase Is Tyrosine-phosphorylated after β1-Integrin Stimulation in B Cells and Binds to p130cas

Anne Astier;Hava Avraham;Serge N. Manie;Jerome Groopman.
Journal of Biological Chemistry (1997)

243 Citations

Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha.

Hideki Kawai;Huchun Li;Shalom Avraham;Shuxian Jiang.
International Journal of Cancer (2003)

243 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hava Avraham

Kari Alitalo

Kari Alitalo

University of Helsinki

Publications: 79

Ramesh K. Ganju

Ramesh K. Ganju

The Ohio State University

Publications: 25

Erica A. Golemis

Erica A. Golemis

Fox Chase Cancer Center

Publications: 24

Anne J. Ridley

Anne J. Ridley

University of Bristol

Publications: 22

Jean-Antoine Girault

Jean-Antoine Girault

Inserm

Publications: 22

Napoleone Ferrara

Napoleone Ferrara

University of California, San Diego

Publications: 22

David D. Schlaepfer

David D. Schlaepfer

University of California, San Diego

Publications: 20

Jerome E. Groopman

Jerome E. Groopman

Beth Israel Deaconess Medical Center

Publications: 20

Ravi Salgia

Ravi Salgia

City Of Hope National Medical Center

Publications: 17

Allen M. Samarel

Allen M. Samarel

Loyola University Chicago

Publications: 17

Joseph Schlessinger

Joseph Schlessinger

Yale University

Publications: 16

Shalom Avraham

Shalom Avraham

Beth Israel Deaconess Medical Center

Publications: 16

Jun-Lin Guan

Jun-Lin Guan

University of Cincinnati Medical Center

Publications: 15

Marc G. Achen

Marc G. Achen

St Vincents Institute of Medical Research

Publications: 15

Avindra Nath

Avindra Nath

National Institutes of Health

Publications: 14

Steven A. Stacker

Steven A. Stacker

Peter MacCallum Cancer Centre

Publications: 14

Trending Scientists

Stéphane Gaubert

Stéphane Gaubert

École Polytechnique

Ashok K. Ganguli

Ashok K. Ganguli

Indian Institute of Technology Delhi

Ann Van Loey

Ann Van Loey

KU Leuven

Giuseppe Pezzotti

Giuseppe Pezzotti

Kyoto Institute of Technology

Koen Kramer

Koen Kramer

Wageningen University & Research

Loyd M. Wax

Loyd M. Wax

Agricultural Research Service

Buko Lindner

Buko Lindner

Brigham and Women's Hospital

Donald H. Dean

Donald H. Dean

The Ohio State University

J. Michael Fritsch

J. Michael Fritsch

Pennsylvania State University

Anna Maria Mercuri

Anna Maria Mercuri

University of Modena and Reggio Emilia

José J. Rodríguez

José J. Rodríguez

University of the Basque Country

Patricia L. Dobkin

Patricia L. Dobkin

McGill University

Mark D. Rapport

Mark D. Rapport

University of Central Florida

Moshe Talpaz

Moshe Talpaz

University of Michigan–Ann Arbor

Wayne A. Ray

Wayne A. Ray

Vanderbilt University

Robert C. Myers

Robert C. Myers

Perimeter Institute

Something went wrong. Please try again later.